LENVATINIB for Bone neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where LENVATINIB was used for Bone neoplasm.
Most Reported Side Effects for LENVATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 4,262 | 12.6% | 321 | 2,714 |
| Hypertension | 4,152 | 12.3% | 405 | 2,522 |
| Fatigue | 3,603 | 10.7% | 208 | 2,023 |
| Decreased appetite | 3,257 | 9.7% | 363 | 2,209 |
| Malignant neoplasm progression | 2,929 | 8.7% | 1,549 | 1,298 |
| Nausea | 2,492 | 7.4% | 160 | 1,637 |
| Blood pressure increased | 2,228 | 6.6% | 104 | 1,411 |
| Vomiting | 1,962 | 5.8% | 122 | 1,458 |
| Asthenia | 1,643 | 4.9% | 122 | 1,180 |
| Malaise | 1,602 | 4.7% | 241 | 989 |
| Weight decreased | 1,529 | 4.5% | 106 | 901 |
| Dehydration | 1,526 | 4.5% | 97 | 1,375 |
| Pyrexia | 1,438 | 4.3% | 134 | 1,149 |
| Hypothyroidism | 1,375 | 4.1% | 165 | 698 |
| Headache | 1,268 | 3.8% | 50 | 810 |
Other Indications for LENVATINIB
Endometrial cancer (6,770)
Hepatocellular carcinoma (5,384)
Renal cell carcinoma (3,849)
Renal cancer (2,862)
Thyroid cancer (2,668)
Uterine cancer (2,233)
Hepatic cancer (1,017)
Clear cell renal cell carcinoma (935)
Product used for unknown indication (916)
Papillary thyroid cancer (501)
Other Drugs Used for Bone neoplasm
LENALIDOMIDE (55)
PALBOCICLIB (53)
DENOSUMAB (48)
PAZOPANIB (37)
ENZALUTAMIDE (24)
CABOZANTINIB S-MALATE (12)
POMALIDOMIDE (9)
AXITINIB (8)
EVEROLIMUS (8)
METHOTREXATE (8)